 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 May 1995 | Volume 122 Issue 9 | Pages 701-714
Purpose: To review the current understanding of the mechanisms and treatment of the long QT interval syndromes and torsade de pointes.
Data Sources: Personal databases of the authors and a search of the MEDLINE database from 1966 to 1994.
Study Selection: Experimental and clinical studies and topical reviews on the electrophysiologic mechanisms and treatment of torsade de pointes were analyzed.
Results: The long QT interval syndromes have been classified into acquired and hereditary forms, both of which are associated with a characteristic type of life-threatening polymorphic ventricular tachycardia called torsade de pointes. The acquired form is caused by various agents and conditions that reduce the magnitude of outward repolarizing K+ currents, enhance inward depolarizing Na+ or Ca2+ currents, or both, thereby triggering the development of early afterdepolarizations that initiate the tachyarrhythmia. The hereditary form appears to result from an abnormal response to adrenergic or sympathetic nervous system stimulation. At least some cases of the hereditary long QT interval syndromes may result from a single gene defect that alters the intracellular regulatory proteins responsible for the modulation of K+ channel function. Treatment of the acquired form is primarily directed at identifying and withdrawing the offending agent, although emergent therapy using maneuvers and agents that favorably modulate transmembrane ion currents can be lifesaving. In torsade de pointes associated with the hereditary long QT interval syndromes, early diagnosis leading to treatments designed to both shorten the QT interval and block the ß-adrenergic-induced instability of the QT interval is essential.
Conclusions: The long QT interval syndromes and torsade de pointes are potentially life-threatening conditions caused by various agents, conditions, and genetic defects. The mechanisms responsible for these conditions and available treatment options for them are reviewed.
Author and Article Information
From Stanford University School of Medicine, Stanford, California.
REVIEW
Electrophysiologic Mechanisms of the Long QT Interval Syndromes and Torsade de Pointes
Requests for Reprints: Ruey J. Sung, MD, Cardiac Electrophysiology and Arrhythmia Service, Stanford University Hospital, Room H2146, 300 Pasteur Drive, Stanford, CA 94305.
Grant Support: Dr. Tan was supported by the Netherlands Heart Foundation (Grant R93314) and the Durrer Fund Netherlands. Dr. Hou was supported by the MacKay Memorial Hospital, Taipei, Taiwan.
This article has been cited by other articles:
|
|
 |
|
  H. L. Tan, A. Bardai, W. Shimizu, A. J. Moss, E. Schulze-Bahr, T. Noda, and A. A. M. Wilde Genotype-Specific Onset of Arrhythmias in Congenital Long-QT Syndrome: Possible Therapy Implications Circulation, November 14, 2006; 114(20): 2096 - 2103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D P J Hunt and K Tang Long QT syndrome presenting as epileptic seizures in an adult Emerg. Med. J., August 1, 2005; 22(8): 600 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rasty, N. B. Amin, H. N. Sabbah, T. Mishima, S. Borzak, and J. E. Tisdale Influence of IV Haloperidol on Ventricular Repolarization and Monophasic Action Potential Duration in Anesthetized Dogs Chest, May 1, 2004; 125(5): 1821 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. TEICH Side Effects of Ziprasidone Am J Psychiatry, July 1, 2003; 160(7): 1355 - 1356. [Full Text]
|
|
|
|
 |
|
 S. Dineen, K. Withrow, L. Voronovitch, F. Munshi, M. W. Nawbary, and S. Lippmann QTc Prolongation and High-Dose Olanzapine Psychosomatics, April 1, 2003; 44(2): 174 - 175. [Full Text] [PDF]
|
|
|
|
 |
|
 H. L Tan, C. R Bezzina, J. P.P Smits, A. O Verkerk, and A. A.M Wilde Genetic control of sodium channel function Cardiovasc Res, March 15, 2003; 57(4): 961 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Lanfranchi, A. S.M. Shamsuzzaman, M. J. Ackerman, T. Kara, P. Jurak, R. Wolk, and V. K. Somers Sex-Selective QT Prolongation During Rapid Eye Movement Sleep Circulation, September 17, 2002; 106(12): 1488 - 1492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P T Munro and C A Graham Torsade de pointes Emerg. Med. J., September 1, 2002; 19(5): 485 - 486. [Abstract] [Full Text]
|
|
|
|
|
|
L. Boersma, Z. Zetelaki, J. Brugada, and M. Allessie Polymorphic Reentrant Ventricular Tachycardia in the Isolated Rabbit Heart Studied by High-Density Mapping Circulation, June 25, 2002; 105(25): 3053 - 3061. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. N. Singh CIBIS, MERIT-HF, and COPERNICUS Trial Outcomes: Do They Complete the Chapter on -Adrenergic Blockers as Antiarrhythmic and Antifibrillatory Drugs? Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2001; 6(2): 107 - 110. [PDF]
|
|
|
|
 |
|
 A. Mazur, M. E. Anderson, S. Bonney, and D. M. Roden Pause-dependent polymorphic ventricular tachycardia during long-term treatment with dofetilide: A placebo-controlled, implantable cardioverter-defibrillator-based evaluation J. Am. Coll. Cardiol., March 15, 2001; 37(4): 1100 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.L. Tan and K.I. Lie Treatment of tachyarrhythmias during pregnancy and lactation Eur. Heart J., March 2, 2001; 22(6): 458 - 464. [PDF]
|
|
|
|
 |
|
 D S Semama, S Bernardini, S Louf, B Laurent-Atthalin, and J-B Gouyon Effects of cisapride on QTc interval in term neonates Arch. Dis. Child. Fetal Neonatal Ed., January 1, 2001; 84(1): 44F - 46. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. E. O'Brien, M. Apkon, C. I. Berul, H. T. Patel, K. Saupe, M. Spindler, J. S. Ingwall, and R. Zahler Phenotypical features of long Q-T syndrome in transgenic mice expressing human Na-K-ATPase alpha 3-isoform in hearts Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2133 - H2142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Viskin, R Fish, D Zeltser, B Belhassen, K Heller, D Brosh, S Laniado, and H V Barron Arrhythmias in the congenital long QT syndrome: how often is torsade de pointes pause dependent? Heart, June 1, 2000; 83(6): 661 - 666. [Abstract] [Full Text]
|
|
|
|
|
|
P. Gajwani, L. Pozuelo, and G. E. Tesar QT Interval Prolongation Associated With Quetiapine (Seroquel) Overdose Psychosomatics, February 1, 2000; 41(1): 63 - 65. [Full Text]
|
|
|
|
|
|
S. Doshi and B. N. Singh Reducing Perioperative Cardiac Risk in Noncardiac Surgery: A Time to Delineate Simpler Strategies? Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(2): 69 - 75. [PDF]
|
|
|
|
 |
|
 D. Weinshenker, A. Wei, L. Salkoff, and J. H. Thomas Block of an ether-a-go-go-Like K+ Channel by Imipramine Rescues egl-2 Excitation Defects in Caenorhabditis elegans J. Neurosci., November 15, 1999; 19(22): 9831 - 9840. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Sosunov, R. Z. Gainullin, P. Danilo Jr., E. P. Anyukhovsky, M. Kirchengast, and M. R. Rosen Electrophysiological Effects of LU111995 on Canine Hearts: In Vivo and In Vitro Studies J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 146 - 152. [Abstract] [Full Text]
|
|
|
|
|
|
J. Cheng, K. Kamiya, W. Liu, Y. Tsuji, J. Toyama, and I. Kodama Heterogeneous distribution of the two components of delayed rectifier K+ current: a potential mechanism of the proarrhythmic effects of methanesulfonanilideclass III agents Cardiovasc Res, July 1, 1999; 43(1): 135 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Basilico Cardiovascular Disease in Athletes Am. J. Sports Med., January 1, 1999; 27(1): 108 - 121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L Tan, A. A M Wilde, and R. J G Peters Suppression of torsades de pointes by atropine Heart, January 1, 1998; 79(1): 99 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Bernardini, D S Semama, F Huet, C Sgro, and J B Gouyon Effects of cisapride on QTc interval in neonates Arch. Dis. Child. Fetal Neonatal Ed., November 1, 1997; 77(3): 241F - 243. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Katapadi, G. Kostandy, M. Katapadi, K.M.A. Hussain, D. Schifter, and G. Kostandy A Review of Erythromycin-Induced Malignant Tachyarrhythmia-- Torsade de Pointes: A Case Report Angiology, September 1, 1997; 48(9): 821 - 826. [Abstract] [PDF]
|
|
|
|
|
|
L. Carlsson, G. J Amos, B. Andersson, L. Drews, G. Duker, and G. Wadstedt Electrophysiological Characterization of the Prokinetic Agents Cisapride and Mosapride in Vivo and in Vitro: Implications for Proarrhythmic Potential? J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 220 - 227. [Abstract] [Full Text]
|
|
Article
